MHRA Performance Data for Assessment of Clinical Trials and Established Medicines MHRA Performance Data for Assessment of Clinical Trials and Established Medicines MHRA has published MHRA performance metrics for clinical trials... MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
Revised Clinical Trials Information System (CTIS) Transparency Rules Revised Clinical Trials Information System (CTIS) Transparency Rules EMA has adopted revised transparency rules for the publication of information... Revised Clinical Trials Information System (CTIS) Transparency Rules
UKNI Mark and CE Mark Guidance Pages Updated UKNI Mark and CE Mark Guidance Pages Updated MHRA has updated the ‘Using the UKNI marking‘ and... UKNI Mark and CE Mark Guidance Pages Updated
MHRA Webinar Recording – International Recognition Procedure MHRA Webinar Recording – International Recognition Procedure On 14 September, MHRA hosted a webinar to provide potential applicants with the... MHRA Webinar Recording – International Recognition Procedure
EMA Management Board – October 2023 Meeting Highlights EMA Management Board – October 2023 Meeting Highlights The European Medicines Agency (EMA) has published the highlights of the EMA... EMA Management Board – October 2023 Meeting Highlights
MHRA Publishes Marketing Authorisations Granted 15 October to 31 October MHRA Publishes Marketing Authorisations Granted 15 October to 31 October The Medicines and Healthcare products Regulatory Agency (MHRA) granted one... MHRA Publishes Marketing Authorisations Granted 15 October to 31 October
MHRA Board Meeting Recording – 19 September 2023 MHRA Board Meeting Recording – 19 September 2023 The recording and board meeting pack of the MHRA Board Meeting... MHRA Board Meeting Recording – 19 September 2023
EMA HMPC Meeting Report – September 2023 EMA HMPC Meeting Report – September 2023 EMA’s Committee on Herbal Medicinal Products (HMPC) has published the report from their... EMA HMPC Meeting Report – September 2023
Nitrosamines – Revised EMA Q&A Nitrosamines – Revised EMA Q&A An amended version of the Questions and answers for marketing authorisation holders/applicants on... Nitrosamines – Revised EMA Q&A
UK-Wide Licensing for Human Medicines Guidance Published UK-Wide Licensing for Human Medicines Guidance Published MHRA has published guidance for the UK-wide licensing of human medicines on the... UK-Wide Licensing for Human Medicines Guidance Published
Microplastics – Publication of Commission Regulation 2023/2055 in OJEU Microplastics – Publication of Commission Regulation 2023/2055 in OJEU The Commission Regulation (EU) 2023/2055 of 25 September 2023... Microplastics – Publication of Commission Regulation 2023/2055 in OJEU
MHRA Publishes Marketing Authorisations Granted 1 September to 14 September 2023 MHRA Marketing Authorisations Granted 1 September to 14 September 2023 MHRA granted three OTC licences during 1 – 14 September... MHRA Publishes Marketing Authorisations Granted 1 September to 14 September 2023
